11/5/2024AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...

11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Big Pharma Doubles Down on China (The Wire China)

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA

11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso

11/4/2024BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...

11/4/2024The 10th Round of National Level VBP of Drugs Officially Initiated wit...

11/4/2024NMPA Signs Letter of Intent on Cooperation with Danish Medicines Agenc...

11/1/2024Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...

11/1/2024NMPA Issues Announcement for Applicability of ICH Guideline M12

11/1/2024Recent Executive Moves

10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...

10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...

10/30/2024Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong

10/30/2024China's BMI Negotiation Spotlight Record Number of Orphan Drugs

10/30/2024AstraZeneca China President Under Investigation Amid Broader Scrutiny ...

10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...

10/30/2024China Set to Achieve Full Drug and Medical Consumables Traceability by...

10/29/2024SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024 (with Annual M...

10/29/2024Nine Pharma MNCs Grew Their Combined China Revenue at 12.5% CAGR betwe...

10/29/2024GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...

10/29/2024Innovative Drugs Lead the 2024 Health Insurance Price Negotiations in ...

10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...

10/28/2024China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...

10/28/2024China Begins 2024 NRDL Negotiations with Key Focus on Innovation and P...

Page:28/367 Total number of articles:11001: [First][<<] [26] [27] [28] [29] [30] [>>] [End]